Skip to Main Nav Skip to Content

ZOMIG References

References:

  1. Ryan RE Jr, Diamond S, Giammarco RAM, et al. Efficacy of zolmitriptan at early time-points for the acute treatment of migraine and treatment of recurrence. CNS Drugs. 2000;13:215-226.
  2. ZOMIG® (zolmitriptan) Tablets and ZOMIG-ZMT® (zolmitriptan) Orally Disintegrating Tablets Prescribing Information, AstraZeneca Pharmaceuticals LP, Wilmington, DE.
  3. Spierings ELH, Rapoport AM, Dodick DW, Charlesworth B. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs. 2004;18:1133-1141.
  4. Dowson AJ, MacGregor EA, Purdy RA, et al. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia. 2002;22:101-106.
  5. Gawel M, Aschoff J, May A, Charlesworth BR, for the REALIZE study team. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine—results from phase I of the REALIZE study. Headache. 2005;45:7-16.
  6. Yates R, Sorensen J, Bergstrom M, et al. Distribution of intranasal 11C-zolmitriptan assessed by positron emission tomography. Cephalalgia. 2005;25:1103-1109.
  7. ZOMIG® (zolmitriptan) Nasal Spray Prescribing Information, AstraZeneca Pharmaceuticals LP, Wilmington, DE.
  8. Wild MJ, McKillop D, Butters CJ. Determination of the human cytochrome P450 isoforms involved in the metabolism of zolmitriptan. Xenobiotica. 1999;29:847-857.
  9. Rapoport AM, Ramadan NM, Adelman JU, et al. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range–finding study. Neurology. 1997;49:1210-1218.
  10. Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L. Speed of onset, efficacy, and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS Drugs. 2005;19:125-136.
  11. Buchholz D. Heal Your Headache: The 1-2-3 Program for Taking Charge of Your Pain. New York, NY: Workman Publishing Co Inc; 2002:62,100.
  12. Constantine LM, Scott S. Migraine: The Complete Guide. New York, NY: Bantam Doubleday Dell Publishing Group Inc; 1994.
  13. Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American migraine study II. Headache. 2001;41:638-640.
  14. Bond JT, Thompson C, Galinsky E, Prottas Do. Highlights of the National Study of the Changing Workforce No 3. New York, NY: Families and Work Institute. 2002: 14-15.
  15. Barletta M. Marketing to Women: How to Increase Your Share of the World’s Largest Market. 2nd ed. Chicago, IL: Dearborn Trade Publishing; 2006:59-61.